SageMedic Corp, headquartered in California, is revolutionizing cancer diagnostics with a scalable platform that transcends the limitations of genomic testing, delivering results within just one week. Our pioneering OncotestTM harnesses a machine learning enabled 3D live cell sensitivity and resistance assay, empowering oncologists to make informed treatment decisions for improved patient outcomes through functional tumor profiling. Unlike traditional methods that rely on slow and often unreliable tumor cell proliferation, the Oncotest™ is both faster and more dependable. Our vision is to elevate personalized cancer therapy to the forefront, fostering hope and enhancing the quality of life for each patient. At SageMedic Corp, we are committed to making tailored therapy the new standard in cancer care.